tirzepatide vs semaglutide head to head vs. Semaglutide: What the Head-to-Head Trial Showed — Shreveport Direct Care Tirzepatide vs Semaglutide: 2026 Head-to-Head

We treat the couple, not just the woman

Valid reasons include: Inadequate weight loss on Wegovy despite 6+ months at 2.4 mg Insurance coverage change (Zepbound covered, Wegovy not) Persistent side effects on semaglutide that may improve with tirzepatide's different receptor profile Patient preference for potentially greater weight loss Invalid or questionable reasons: Switching after only 8 to 12 weeks on Wegovy (insufficient time to assess response) Switching due to transient nausea during titration (both medications cause nausea) Switching based on anecdotal reports without clinical rationale Step 2: Choose washout vs overlap strategy

Our approach combines diagnostic insight, clinical expertise, and ongoing monitoring to create personalized programs that target the root causes of weight gain

Some cows were not inseminated and were instead used as recipients for the farms embryo transfer program

The ICD-10 code for acute blood loss anemia is D62

NAD supplements may trigger additional GI upset in some users